Along with its needed effects, cladribine (the active ingredient contained in Leustatin) may cause some unwanted effects. Some side effects will have signs or symptoms that you can see or feel. Your doctor may watch for others by doing certain tests.
Also, because of the way cancer medicines act on the body, there is a chance that they might cause other unwanted effects that may not occur until months or years after the medicine is used. These delayed effects may include certain types of cancer. Discuss these possible effects with your doctor.
If any of the following side effects occur while taking cladribine, check with your doctor or nurse as soon as possible:
This medicine may also cause the following side effects that your doctor will watch out for:
Very common (10% or more): Neutropenia, thrombocytopenia, anemia, purpuraCommon (1% to 10%): Febrile neutropeniaUncommon (0.1% to 1%): Bone marrow suppression with prolonged pancytopenia, aplastic anemia, hypereosinophilia, myelodysplastic syndromePostmarketing reports: Hemolytic anemia, anemia, febrile neutropenia
Common (1% to 10%): Renal failure (including renal failure acute, renal impairment)
Very common (10% or more): Nausea (28%), anorexia (17%), vomiting (13%), diarrhea (10%)Common (1% to 10%): Constipation, abdominal pain, flatulenceUncommon (0.1% to 1%): Mucositis
Very common (10% or more): Rash (28%), diaphoresis, pruritusCommon (1% to 10%): Hyperhidrosis, petechiae, ecchymosis, urticaria, petechiaeUncommon (0.1% to 1%): Stevens-Johnson syndrome, toxic skin eruption, toxic epidermal necrolysisRare (less than 0.1%): AlopeciaVery rare (less than 0.01%): Epidermal necrolysisPostmarketing reports: Hypereosinophilia
Very common (10% or more): HeadacheCommon (1% to 10%): Dizziness, somnolenceUncommon (0.1% to 1%): Depressed level of consciousness, neurological toxicity (including peripheral sensory neuropathy, motor neuropathy (paralysis), polyneuropathy, paraparesis)
Very common (10% or more): Administration site reaction
Uncommon (0.1% to 1%): Tumor lysis syndrome, metabolic acidosis
Common (1% to 10%): Edema, tachycardia, myocardial ischemia, peripheral edemaRare (less than 0.1%): Heart failure, arrhythmia, heart murmur, hypotension, thrombosis
Common (1% to 10%): Arthralgia, myalgia, painUncommon (0.1% to 1%): Muscular weakness, paraparesis
Very common (10% or more): CoughCommon (1% to 10%): Pulmonary interstitial infiltrates (including lung infiltration, interstitial lung disease, pneumonitis and pulmonary fibrosis), abnormal breath sounds, abnormal chest sounds, dyspnea, rales
Common (1% to 10%): Hypersensitivity
Uncommon (0.1% to 1%): Increases in bilirubin, increases in transaminases, jaundice
Very common (10% or more): Infection (unspecified) (up to 28%)Common (1% to 10%): Bacteremia, cellulitis, localized infection, pneumonia, septic shock, serious infection, opportunistic infection
Postmarketing reports: Conjunctivitis
Very common (10% or more): Fatigue, pyrexiaCommon (1% to 10%): Asthenia, chills, malaise, localized edema, chills, weight loss
Postmarketing reports: Secondary malignancies
Common (1% to 10%): Confusion, anxiety, insomnia
Black, tarry stools
blood in urine 
cough or hoarseness, accompanied by fever or chills 
fever
lower back or side pain, accompanied by fever or chills
painful or difficult urination, accompanied by fever or chills
 pinpoint red spots on skin
unusual bleeding or bruising 
Skin rash
Pain or redness at place of injection
 shortness of breath
stomach pain
 swelling of feet or lower legs
unusually fast heartbeat 
Anemia
low white cell counts in blood 
Headache
loss of appetite
nausea
unusual tiredness
vomiting
Constipation
diarrhea
dizziness
general feeling of discomfort or illness
itching
muscle or joint pain
sweating
 trouble in sleeping
weakness